CD36 and metabolic dysfunction-associated steatotic liver disease: Consistent with human observations and previous rodent models, male mice in the study had more severe outcomes compared to the female mice.45,46 Both showed similar trends in terms of NAFLD prevalence/score, CD36 levels, and methylation changes, as well as hypomethylation at the same DMRs.